Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey

View ORCID ProfileAna Maria Baptista Menezes, View ORCID ProfileCesar G Victora, View ORCID ProfileFernando P Hartwig, View ORCID ProfileMariangela F Silveira, View ORCID ProfileBernardo L Horta, View ORCID ProfileAluisio J D Barros, View ORCID ProfileFernando C Whermeister, View ORCID ProfileMarilia A Mesenburg, View ORCID ProfileLucia C Pellanda, View ORCID ProfileOdir A Dellagostin, View ORCID ProfileClaudio J Struchiner, View ORCID ProfileMarcelo N Burattini, View ORCID ProfileFernando C Barros, View ORCID ProfilePedro C Hallal
doi: https://doi.org/10.1101/2020.08.10.20171942
Ana Maria Baptista Menezes
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana Maria Baptista Menezes
  • For correspondence: anamene.epi@gmail.com
Cesar G Victora
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cesar G Victora
  • For correspondence: cvictora@gmail.com
Fernando P Hartwig
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando P Hartwig
  • For correspondence: fernandophartwig@gmail.com
Mariangela F Silveira
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mariangela F Silveira
  • For correspondence: mariangelafreitassilveira@gmail.com
Bernardo L Horta
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernardo L Horta
  • For correspondence: blhorta@gmail.com
Aluisio J D Barros
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aluisio J D Barros
  • For correspondence: abarros.epi@gmail.com
Fernando C Whermeister
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando C Whermeister
  • For correspondence: fcwehrmeister@gmail.com
Marilia A Mesenburg
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marilia A Mesenburg
  • For correspondence: mariliaepi@gmail.com
Lucia C Pellanda
2 Fundacao Universidade Federal de Ciencias de Saude de Porto Alegre;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucia C Pellanda
  • For correspondence: pellanda@ufcspa.edu.br
Odir A Dellagostin
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Odir A Dellagostin
  • For correspondence: odirad@gmail.com
Claudio J Struchiner
3 Fundacao Getulio Vargas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claudio J Struchiner
  • For correspondence: claustru@gmail.com
Marcelo N Burattini
4 Universidade de Sao Paulo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcelo N Burattini
  • For correspondence: mnburatt@gmail.com
Fernando C Barros
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando C Barros
  • For correspondence: fcbarros.epi@gmail.com
Pedro C Hallal
1 Universidade Federal de Pelotas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pedro C Hallal
  • For correspondence: prchallal@gmail.com
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. A frequently-cited early study from China suggested that 86% of all infections were undocumented, which was used as indirect evidence that patients were asymptomatic. Using data from the most recent wave of the EPICOVID19 study, a nationwide household-based survey including 133 cities from all states of Brazil, we estimated the proportion of people with and without antibodies for SARS-CoV-2 who were asymptomatic, which symptoms were most frequently reported, the number of symptoms reported and the association between symptomatology and socio-demographic characteristics. We were able to test 33,205 subjects using a rapid antibody test that was previously validated. Information on symptoms was collected before participants received the test result. Out of 849 (2.7%) participants who tested positive for SARS-CoV-2 antibodies, only 12.1% (95%CI 10.1-14.5) reported no symptoms since the start of the pandemic, compared to 42.2% (95%CI 41.7-42.8) among those who tested negative. The largest difference between the two groups was observed for changes in smell or taste (56.5% versus 9.1%, a 6.2-fold difference). Symptoms change in smell or taste, fever and myalgia were most likely to predict positive test results as suggested by recursive partitioning tree analysis. Among individuals without any of these three symptoms (74.2% of the sample), only 0.8% tested positive, compared to 18.3% of those with both fever and changes in smell or taste. Most subjects with antibodies against SARS-CoV-2 in Brazil are symptomatic, even though most present only mild symptoms.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We acknowledge the support from Instituto Serrapilheira, Pastoral da Crianca, the Brazilian Collective Health Association (ABRASCO) and JBS initiative Fazer o Bem Faz Bem

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was provided by the Brazilian National Ethics Committee, process number 30721520710015313

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will become publicly available 30 days after completion of the fieldwork at http://www.epicovid19brasil.org/

http://www.epicovid19brasil.org/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted August 12, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey
Ana Maria Baptista Menezes, Cesar G Victora, Fernando P Hartwig, Mariangela F Silveira, Bernardo L Horta, Aluisio J D Barros, Fernando C Whermeister, Marilia A Mesenburg, Lucia C Pellanda, Odir A Dellagostin, Claudio J Struchiner, Marcelo N Burattini, Fernando C Barros, Pedro C Hallal
medRxiv 2020.08.10.20171942; doi: https://doi.org/10.1101/2020.08.10.20171942
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey
Ana Maria Baptista Menezes, Cesar G Victora, Fernando P Hartwig, Mariangela F Silveira, Bernardo L Horta, Aluisio J D Barros, Fernando C Whermeister, Marilia A Mesenburg, Lucia C Pellanda, Odir A Dellagostin, Claudio J Struchiner, Marcelo N Burattini, Fernando C Barros, Pedro C Hallal
medRxiv 2020.08.10.20171942; doi: https://doi.org/10.1101/2020.08.10.20171942

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (412)
  • Dentistry and Oral Medicine (69)
  • Dermatology (47)
  • Emergency Medicine (142)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4843)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (626)
  • Health Policy (318)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5326)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (93)
  • Medical Ethics (25)
  • Nephrology (75)
  • Neurology (685)
  • Nursing (42)
  • Nutrition (114)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (205)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (778)
  • Public and Global Health (1810)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)